Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 Slide Shows
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
CES 2010 Coverage 

Follow Us
RTTNews on Twitter RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube

Font Down Font Up
Sun Pharma Announces US FDA Approval For Generic Strattera Capsules
11/26/2009 6:05 AM ET

(RTTNews) - Sun Pharma announced that the company was granted tentative approval from US FDA for an Abbreviated New Drug Application (ANDA) for generic Strattera, atomoxetine hydrochloride capsules.

These atomoxetine hydrochloride capsules are therapeutically equivalent to Strattera capsules from Eli Lilly in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg strengths. Atomoxetine hydrochloride capsules have annual sales of about $500 million in the US. Strattera capsules are indicated for the treatment of attention deficit hyperactivity disorder.

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com



Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print           Follow Us RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube

     
Top Stories
International Flavors & Fragrances Q4 Profit Edges Down - Update

Agrium Q4 Profit Tumbles - Update

Coventry Health Q4 Profit Rises; Guides FY10 - Update

Asian Markets End In Positive Territory On Bargain Hunting

Cognizant Technology Q4 Profit Rises; Issues Q1, FY10 Outlook Above View - Update

Earnings
Pansoft's Strong Quarter - Stocks To Watch

Gaylord Entertainment Slips To Loss In Q4 - Quick Facts

Rodman & Renshaw Capital Turns To Proft In Q4 - Quick Facts

Martin Marietta Materials Turns To Q4 Loss - Quick Facts

Rubicon's Glowing Outlook - Stocks To Watch

US Market Commentary
Stocks May Open Higher As Traders Go Bargain Hunting - U.S. Commentary

Wall Street Poised For Early Gains On Bargain Hunting

Stocks End Lackluster Trading Day Firmly In The Red - U.S. Commentary

Choppy Trading Persists On Wall Street In The Mid-Afternoon - U.S. Commentary

Stocks Continue To Show A Lack Of Direction In The Early Afternoon - U.S. Commentary

US Economic News
Cloudy Jobs Picture Accentuating Consumer Worries

Political News
196 More Charge-Sheeted In Philippines Massacre

Tymoshenko Bloc To Challenge Ukraine Presidential Election

Chinese Quake Activist Gets 5 Year Jail Term

Iraq War Critic Democrat Murtha Dies

Representative John Murtha Passes Away




 
Rep. Murtha Dies; Nuclear Tensions With Iran
02/08/10 05:00
Dow Closes Below 10,000
02/08/10 04:45
Stocks Mixed In Mid-Day Trading
02/08/10 02:31
 

Today's Stocks to Watch
PSOF - Pansoft Company Limited
RBCN - RUBICON TECHNOLOGY,
NTUR.OB - Natural Blue Resources, Inc.
SNSS - Sunesis Pharmaceuticals Inc.
SITO.OB - Single Touch Systems Inc.
MKTX - MARKETAXESS HOLDINGS INC


Traders May Go Bargain Hunting Following Recent Weakness - RTTNews Daily Market Analysis
The major U.S. index futures are pointing to a modestly higher opening on Monday, with stocks likely to regain some ground after trending lower in recent weeks. The upward momentum for the markets is partly due to some positive earnings news, which has helped traders to shrug off recent economic uncertainty. Some traders are also likely looking to go bargain hunting following recent weakness.
The Week In Washington  Lawmakers spent a busy week in Washington discussing the recently unveiled Fiscal Year 2011 budget, and the Democrats new jobs agenda

 

Copyright © 2010 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service| How To Use RTTNews.com| Advertise| Privacy| Buy Content | RSS